CLINICAL_TRIALS
trial_result
· 2014-07-09
Clinical Trial Update: Temozolomide in Treating Patients With Progressive Low-Grade Glioma [Phase 2]
Summary
This is a Phase 2 trial update indicating completion of a study of temozolomide in patients with progressive low-grade glioma.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Duke University | Conditions: Brain and Central Nervous System Tumors | Phase 2 | Status: COMPLETED